Literature DB >> 27984715

Metformin: Restraining Nucleocytoplasmic Shuttling to Fight Cancer and Aging.

Jorge Iván Castillo-Quan1, T Keith Blackwell2.   

Abstract

In this issue of Cell, Wu et al. employed C. elegans and human cell experiments to identify a pathway through which metformin increases lifespan and inhibits growth. A key transcriptional target, ACAD10, is activated when metformin induces nuclear exclusion of the GTPase RagC, thereby inhibiting mTORC1 through an unexpected mechanism.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27984715     DOI: 10.1016/j.cell.2016.11.058

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  15 in total

Review 1.  TOR Signaling in Caenorhabditis elegans Development, Metabolism, and Aging.

Authors:  T Keith Blackwell; Aileen K Sewell; Ziyun Wu; Min Han
Journal:  Genetics       Date:  2019-10       Impact factor: 4.562

Review 2.  Metformin: Mechanisms in Human Obesity and Weight Loss.

Authors:  Armen Yerevanian; Alexander A Soukas
Journal:  Curr Obes Rep       Date:  2019-06

3.  lncRNA PCBP1-AS1 Aggravates the Progression of Hepatocellular Carcinoma via Regulating PCBP1/PRL-3/AKT Pathway.

Authors:  Tianping Luo; Yuan Gao; Guangyan Zhangyuan; Xiaoliang Xu; Cailin Xue; Lei Jin; Wenjie Zhang; Chunfu Zhu; Beicheng Sun; Xihu Qin
Journal:  Cancer Manag Res       Date:  2020-07-06       Impact factor: 3.989

4.  Immunohistochemistry biomarker TP53 expression predicts the survival of thymomas.

Authors:  Dongliang Bian; Liting Zhao; Xuelin Zhang; Fanzhen Lv; Zhenghong Zhu; Hui Qiu; Huibiao Zhang
Journal:  Gland Surg       Date:  2020-04

5.  Chloride intracellular channel 1 regulates the antineoplastic effects of metformin in gallbladder cancer cells.

Authors:  Yongchen Liu; Zheng Wang; Maolan Li; Yuanyuan Ye; Yi Xu; Yichi Zhang; Ruiyan Yuan; Yunpeng Jin; Yajuan Hao; Lin Jiang; Yunping Hu; Shili Chen; Fatao Liu; Yijian Zhang; Wenguang Wu; Yingbin Liu
Journal:  Cancer Sci       Date:  2017-05-22       Impact factor: 6.716

6.  Metformin inhibits cervical cancer cell proliferation by modulating PI3K/Akt-induced major histocompatibility complex class I-related chain A gene expression.

Authors:  Chenglai Xia; Chang Liu; Zhihong He; Yantao Cai; Jinman Chen
Journal:  J Exp Clin Cancer Res       Date:  2020-07-06

7.  Transcriptomic landscape profiling of metformin-treated healthy mice: Implication for potential hypertension risk when prophylactically used.

Authors:  Yuhong Meng; Rui Xiang; Han Yan; Yiran Zhou; Yuntao Hu; Jichun Yang; Yuan Zhou; Qinghua Cui
Journal:  J Cell Mol Med       Date:  2020-06-11       Impact factor: 5.310

8.  Inhibition of mTORC1 through ATF4-induced REDD1 and Sestrin2 expression by Metformin.

Authors:  Se-Kyeong Jang; Sung-Eun Hong; Da-Hee Lee; Ji-Young Kim; Ji Yea Kim; Sang-Kyu Ye; Jungil Hong; In-Chul Park; Hyeon-Ok Jin
Journal:  BMC Cancer       Date:  2021-07-12       Impact factor: 4.430

9.  Towards natural mimetics of metformin and rapamycin.

Authors:  Alexander Aliper; Leslie Jellen; Franco Cortese; Artem Artemov; Darla Karpinsky-Semper; Alexey Moskalev; Andrew G Swick; Alex Zhavoronkov
Journal:  Aging (Albany NY)       Date:  2017-11-15       Impact factor: 5.682

10.  Metformin Reshapes the Methylation Profile in Breast and Colorectal Cancer Cells

Authors:  Hussein Sabit; Shimaa E Abdel-Ghany; Osama A M Said; Mohamed A Mostafa; Mokhtar El-Zawahry
Journal:  Asian Pac J Cancer Prev       Date:  2018-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.